Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 179-184 , December 2009

Chlamydial protease-like activity factor—insights into immunity and vaccine development

  • Ashlesh K. Murthy

      Affiliations

    • South Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, One UTSA circle, San Antonio, TX 78249, USA
    • ,
  • M. Neal Guentzel

      Affiliations

    • South Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, One UTSA circle, San Antonio, TX 78249, USA
    • ,
  • Guangming Zhong

      Affiliations

    • Department of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229, USA
    • ,
  • Bernard P. Arulanandam

      Affiliations

    • South Texas Center for Emerging Infectious Diseases, Department of Biology, University of Texas at San Antonio, One UTSA circle, San Antonio, TX 78249, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 210 458 5492; fax: +1 210 458 5523.

Received 16 December 2008 ,Revised 24 April 2009 ,Accepted 12 May 2009.

References 

  1. Berry LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, Hansbro PM, et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect. Immun. 2004;72:1019–1028
  2. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 2005;5:149–161
  3. Cong Y, Jupelli M, Guentzel MN, Zhong G, Murthy AK, Arulanandam BP. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection. Vaccine. 2007;25:3773–3780
  4. Crane DD, Carlson JH, Fischer ER, Bavoil P, Hsia RC, Tan C, et al. Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc. Natl. Acad. Sci. U.S.A. 2006;103:1894–1899
  5. Dong F, Pirbhai M, Zhong Y, Zhong G. Cleavage-dependent activation of a Chlamydia-secreted protease. Mol. Microbiol. 2004;52:1487–1494
  6. Dong F, Su H, Huang Y, Zhong Y, Zhong G. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect. Immun. 2004;72:3863–3868
  7. Dong F, Zhong Y, Arulanandam B, Zhong G. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect. Immun. 2005;73:1868–1872
  8. Fan P, Dong F, Huang Y, Zhong G. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for major histocompatibility complex antigen expression. Infect. Immun. 2002;70:345–349
  9. Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, et al. Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 1998;187:487–496
  10. Huang Z, Feng Y, Chen D, Wu X, Huang S, Wang X, et al. Structural basis for activation and inhibition of the secreted Chlamydia protease CPAF. Cell Host Microbe. 2008;4:529–542
  11. Igietseme JU, Magee DM, Williams DM, Rank RG. Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect. Immun. 1994;62:5195–5197
  12. Kiselev AO, Stamm WE, Yates JR, Lampe MF. Expression, processing, and localization of PmpD of Chlamydia trachomatis serovar L2 during the chlamydial developmental cycle. PLoS ONE. 2007;2:e568
  13. Kumar Y, Valdivia RH. Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe. 2008;4:159–169
  14. Li W, Guentzel MN, Seshu J, Zhong G, Murthy AK, Arulanandam BP. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach. Clin. Vaccine Immunol. 2007;14:1537–1544
  15. Li W, Murthy AK, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, et al. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection. J. Immunol. 2008;180:3375–3382
  16. Magee DM, Williams DM, Smith JG, Bleicker CA, Grubbs BG, Schachter J, et al. Role of CD8 T cells in primary Chlamydia infection. Infect. Immun. 1995;63:516–521
  17. Morrison SG, Su H, Caldwell HD, Morrison RP. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4+ T cells but not CD8+ T cells. Infect. Immun. 2000;68:6979–6987
  18. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect. Immun. 2002;70:2741–2751
  19. Morrison SG, Morrison RP. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 2005;175:7536–7542
  20. Murphey C, Murthy AK, Meier PA, Guentzel MN, Zhong G, Arulanandam BP. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell. Immunol. 2006;242:110–117
  21. Murthy AK, Cong Y, Murphey C, Guentzel MN, Forsthuber TG, Zhong G, et al. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect. Immun. 2006;74:6722–6729
  22. Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect. Immun. 2007;75:666–676
  23. Murthy AK, Chaganty BKR, Li W, Guentzel MN, Chambers JP, Seshu J, et al. A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge. FEMS Immunol Med Microbiol. 2009;55:271–279
  24. Pal S, Theodor I, Peterson EM, de la Maza LM. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine. 1997;15:575–582
  25. Pal S, Peterson EM, de la Maza LM. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect. Immun. 2005;73:8153–8160
  26. Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine. 2006;24:766–775
  27. Pirbhai M, Dong F, Zhong Y, Pan KZ, Zhong G. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J. Biol. Chem. 2006;281:31495–31501
  28. Ramsey KH, Soderberg LS, Rank RG. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect. Immun. 1988;56:1320–1325
  29. Rank RG, Ramsey KH, Pack EA, Williams DM. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect. Immun. 1992;60:4427–4429
  30. Rekart ML, Brunham RC. Epidemiology of chlamydial infection: are we losing ground?. Sex Transm. Infect. 2008;84:87–91
  31. Savijoki K, Alvesalo J, Vuorela P, Leinonen M, Kalkkinen N. Proteomic analysis of Chlamydia pneumoniae-infected HL cells reveals extensive degradation of cytoskeletal proteins. FEMS Immunol. Med. Microbiol. 2008;54:375–384
  32. Sharma J, Bosnic AM, Piper JM, Zhong G. Human antibody responses to a Chlamydia-secreted protease factor. Infect. Immun. 2004;72:7164–7171
  33. Sharma J, Dong F, Pirbhai M, Zhong G. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis. Infect. Immun. 2005;73:4414–4419
  34. Sharma J, Zhong Y, Dong F, Piper JM, Wang G, Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 2006;74:1490–1499
  35. Shaw AC, Vandahl BB, Larsen MR, Roepstorff P, Gevaert K, Vandekerckhove J, et al. Characterization of a secreted Chlamydia protease. Cell. Microbiol. 2002;4:411–424
  36. Su H, Caldwell HD. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 1995;63:3302–3308
  37. Su H, Feilzer K, Caldwell HD, Morrison RP. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 1997;65:1993–1999
  38. Zhong G, Fan T, Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 1999;189:1931–1938
  39. Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J. Exp. Med. 2000;191:1525–1534
  40. Zhong G, Fan P, Ji H, Dong F, Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 2001;193:935–942

PII: S0165-0378(09)00467-7

doi: 10.1016/j.jri.2009.05.007

Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 179-184 , December 2009

Article Tools

* Image Usage & Resolution